Sign In

Lara Mott

CEO and Co-founder at ImproveWell, a fast-growing HealthTech SME #EngageToImprove Current Entrepreneur in Residence for BMJ.

Professional Background

Lara Mott has established a remarkable career marked by her entrepreneurial spirit and extensive experience in both the pharmaceutical and financial sectors. As the CEO and Co-founder of ImproveWell LTD, Lara has dedicated herself to enhancing healthcare processes and innovating within the industry. Her leadership role is a testament to her passion for driving improvement in healthcare services through technology and strategic initiatives.

Before founding ImproveWell, Lara demonstrated her entrepreneurial prowess as the BMJ Entrepreneur in Residence at BMJ, where she contributed significantly to the development of healthcare-related projects and initiatives. This role showcased her dedication to enhancing medical communications and ensuring that healthcare professionals have access to pertinent data and technologies designed to improve patient outcomes.

Her extensive experience in investor relations and corporate affairs is impressive. As Vice President of Corporate Affairs at Circassia, she was instrumental in steering corporate strategies that aligned with the organization's goals and vision. Lara's tenure as Deputy Chair of the Communications Advisory Committee at the BioIndustry Association exemplifies her commitment to advancing the representation of biotechnology in the business world. Additionally, her years spent in various investor relations roles—such as Head of Investor Relations and Corporate Communications at Oxford BioMedica and Investor Relations Manager at Apax Partners—highlight her expertise in bridging the gap between scientific innovation and investment opportunities.

Lara's foundation in communications began during her time as a Consultant for Financial Communications at Financial Dynamics (now FTI Consulting). These roles honed her ability to effectively convey complex information in a compelling manner that resonates with diverse stakeholders, an invaluable skill in both corporate and entrepreneurial settings.

Education and Achievements

Lara's educational journey began at Kingston Grammar School, where she held the esteemed position of Vice-Captain. This early leadership role set the stage for her future accomplishments, fostering a strong sense of responsibility and teamwork. She later attended the University of Bristol, where she graduated with a First-Class Honours degree in Pharmacology. Her rigorous academic training in pharmacology has paved the way for her successful career in both healthcare and business, blending scientific understanding with strategic insight.

Throughout her career, Lara has been recognized not only for her exceptional business acumen but also for her contributions to various organizations. As a Board Member at Selfless, she has influenced how organizations approach philanthropy and social impact, leveraging her experience to direct resources where they can make the most significant difference.

Lara's previous role as Director of Investor Relations at GHO Capital Partners LLP, allows her to combine her knowledge of pharmaceuticals and finance seamlessly. She has consistently played a vital role in the strategic direction of organizations, ensuring that investment strategies align with overall business goals.

Notable Contributions

Lara Mott's commitment to healthcare innovation and her skillful navigation of the intersection between biosciences and business are at the forefront of her professional narrative. Her roles have invariably placed her on the leading edge of transformative initiatives within the healthcare sector. Furthermore, her role at Oxford BioMedica highlights her understanding of gene and cell therapy, bringing attention to groundbreaking advancements in the industry.

As she continues her journey with ImproveWell, Lara remains passionate about improving healthcare systems and strategies. She is dedicated to fostering collaboration among healthcare professionals and stakeholders to ensure that the focus remains on patient outcomes and public health.

Related Questions

How did Lara Mott leverage her pharmacology background in her roles in corporate affairs and investor relations?
What inspired Lara Mott to co-found ImproveWell LTD and what are its primary goals?
How did Lara Mott's leadership experience at Kingston Grammar School influence her career trajectory?
What challenges has Lara Mott faced while transitioning between roles in healthcare and finance?
In what ways did Lara Mott contribute to the BioIndustry Association during her time as Deputy Chair of the Communications Advisory Committee?
Lara Mott
Add to my network

Location

London, England, United Kingdom